Application Nr Approved Date Route Status External Links
NDA020169 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Metastatic Prostate Cancer Nilandron Tablets Are Indicated For Use In Combination With Surgical Castration For The Treatment Of Metastatic Prostate Cancer (Stage D 2 ). For Maximum Benefit, Nilandron Treatment Must Begin On The Same Day As Or On The Day After Surgical Castration.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Nilutamide NILUTAMIDE ZINC3874498

Comments